top of page
Artboard 1.png
digital_primary_logo_black.png

Closing the Healthcare Gap - One Test at a Time

OUR MISSION

Vaginal infections are common.

Almost 1 in 2 women encounters bacterial vaginosis and/or vulvovaginal candidiasis every year.

1,2

And so are misdiagnoses.

3

66% of women misdiagnose their yeast infection.

42% of women are misdiagnosed by an OB/GYN.

4

At Shealed, we want to put an end to this.

[1] Peebles, Kathryn et al. “High Global Burden and Costs of Bacterial Vaginosis: A Systematic Review and Meta-Analysis.” Sexually transmitted diseases vol. 46,5 (2019); [2] Gonçalves, Bruna et al. “Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors.” Critical reviews in microbiology vol. 42,6 (2016); [3] Ferris, Daron G et al. “Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis.” Obstetrics and gynecology vol. 99,3 (2002); [4] Hillier, SL et al, “Diagnosis and treatment of vaginal discharge syndromes in community practice settings.” Clin Infect Dis (2020)

OUR SOLUTION

We’re developing a rapid self-test that detects infection-specific factors - providing discreet, fast, and specific results.

packaging.png

Detects molecules that are typical of a bacterial or fungal infection.

Triages patients who can be treated with over-the-counter medications.

Enables safe and discreet
self-diagnosis.

Reduces the high rates
of misdiagnosis.

OUR TEAM

Lucie  Křenková

Microbiology graduate
with experience in
co-managing a family business.

Helena Ignačáková

Scientist experienced 

in diagnostics R&D and in data analysis, bioinformatics enthusiast.

Brigita Benkőová

Microbiological researcher, leader of one of the
clinical diagnostic departments at SMU. 

And many other collaborators, mentors, and advisors.

CURRENT STATUS AND TIMELINE

  COMPLETED  

2024: Theoretical Proof-of-Concept

​​2025: Laboratory Proof-of-Concept Validation & Prototyping Initiation​

  IN PROGRESS  

​​​​​​​2026: Prototype Development & Preclinical Testing

​​​​​​​​2027: Analytical & Clinical Performance Studies

​​​​2028: Notified Body Evaluation

2029+: EU Market Entry & Expansion

SUPPORTED BY

Lifbee Black_edited.png
image.png

Drop us a message!

Or contact us directly at info@shealed.cz

Thanks for keeping in touch!

Asset 17.png
digital_primary_logo_black.png
bottom of page